Role of the lipid emulsion on an injectable formulation of lipophilic KW-3902, a newly synthesized adenosine A1-receptor antagonist

Biological and Pharmaceutical Bulletin

Volumn 25, Issue 4, 2002, Pages 492-498

  Hosokawa, Toshihito ^a   Yamauchi, Masahiro ^a   Yamamoto, Yoshihiko ^a   Iwata, Kenji ^a   Mochizuki, Harumi ^a   Kato, Yasuki ^a  

^a KYOWA HAKKO KOGYO CO LTD   (Japan)

Author keywords

Injection; KW 3902; Lipid emulsion; Liposome; Pharmacokinetics

Indexed keywords

8 (2 NOR 1 ADAMANTYL) 1,3 DIPROPYLXANTHINE; ADENOSINE A1 RECEPTOR ANTAGONIST; DIMETHYL SULFOXIDE; LIPID EMULSION; LIPOSOME; OLEIC ACID; PHOSPHATIDYLCHOLINE; SODIUM CHLORIDE; SODIUM HYDROXIDE; SOYBEAN OIL; 1,3-DIPROPYL-8-(3-NORADAMANTYL)XANTHINE; ADENOSINE RECEPTOR; XANTHINE DERIVATIVE;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; BLOOD COMPONENT; CONTROLLED STUDY; DRUG BINDING; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG DOSAGE FORM; DRUG ELIMINATION; DRUG FORMULATION; DRUG HALF LIFE; DRUG SYNTHESIS; EGG YOLK; EMULSION; IN VITRO STUDY; LIPOPHILICITY; MEAN RESIDENCE TIME; NONHUMAN; RAT; STEADY STATE; ANIMAL; BLOOD; CHEMISTRY; DRUG ANTAGONISM; ELECTRON MICROSCOPY; INTRAVENOUS DRUG ADMINISTRATION; MALE; METABOLISM; SPRAGUE DAWLEY RAT; TISSUE DISTRIBUTION;

ANIMALS; CHEMISTRY, PHARMACEUTICAL; FAT EMULSIONS, INTRAVENOUS; INJECTIONS, INTRAVENOUS; MALE; MICROSCOPY, ELECTRON; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, PURINERGIC P1; TISSUE DISTRIBUTION; XANTHINES;

EID: 0036549723     PISSN: 09186158     EISSN: None     Source Type: Journal    
DOI: 10.1248/bpb.25.492     Document Type: Article

References (50)

1. Collins-Gold L. C., Lyons R. T., Bartholow L. C., Adv. Drug Deliv. Rev., 5, 189-208 (1990).
2. Prankerd R. J., Stella V. J., J. Parenteral Sci. Technol., 44, 139-149 (1990).
3. Simamora P., Dannenfelser R. M., Tabibi S. E., Yalkowsky S. H., J. Parenteral Sci. Technol., 52, 170-172 (1998).
4. Fortner C. L., Grove W. R., Bowie D., Walker M. D., Am. J. Hosp. Pharm., 32, 582-584 (1975).
5. Mizushima Y., Wada Y., Itoh Y., Watanabe K., J. Pharm. Pharmacol., 35, 398-399 (1983).
6. Mizushima Y., Hamano T., Yokoyama K., J. Pharm. Pharmacol., 34, 49-50 (1982).
7. Davis S. S., Washington C., West P., Illum L., Liversidge G., Sternson L., Kirsh R., Ann. N.Y. Acad. Sci., 507, 75-88 (1987).
8. Yamaguchi H., Watanabe K., Hayashi M., Awazu S., J. Pharm. Pharmacol., 36, 766-767 (1984).
9. Coune A., Sculier J. P., Fruhling J., Stryckmans P., Brassinne C., Ghanem G., Laduron C., Atassi G., Ruysschaert J. M., Hildebrand J., Cancer Treatment Reports, 67, 1031-1033 (1983).
10. Gregoriadis G. (ed.), "Liposome Technology," CRC Press Inc., Florida, 1984.
11. Müller R. H., Benita S., Böhm B. (eds.), "Emulsions and Nanosuspensions for the Formulation of Poorly Soluble Drugs," Medpharm Scientific, Stuttgart, 1998.
12. Speiser P. P., Methods Find Exp. Clin. Pharmacol., 13, 337-342 (1991).
13. von Dardel O., Mebius C., Mossberg T., Svensson B., British J. Anaestesia, 55, 41-47 (1983).
14. Hogskilde S., Nielsen J. W., Carl P., Angelo H., Bredgaard S. M., Acta Anaesth. Scand., 31, 289-291 (1987).
15. Shimada J., Suzuki F., Nonaka H., Ishii A., J. Med. Chem., 35, 924-930 (1992).
16. Nonaka H., Ichimura M., takeda M., Kanda T., Shimada J., Suzuki F., Kase H., Br. J. Pharmacol., 117, 1645-1652 (1996).
17. Nagashima K., Karasawa A., Biol. Pharm. Bull., 19, 940-943 (1996).
18. Yamagata T., Kobayashi T., Mizumoto H., Karasawa A., Biol. Pharm. Bull., 17, 1599-1603 (1994).
19. Kusaka H., Nagashima K., Karasawa A., Jpn. J. Pharmacol., 68, 213-216 (1995).
20. Nagashima K., Kusaka H., Karasawa A., Jpn. J. Pharmacol., 67, 349-357 (1995).
21. Yao K., Ina Y., Nagashima K., Ohno T., Karasawa A., Jpn. J. Pharmacol., 84, 310-315 (2000).
22. Hosokawa T., Yamauchi M., Yamamoto Y., Iwata K., Kato Y., Hayakawa E., Chem. Pharm. Bull., 50, 87-91 (2002).
23. Kato Y., Watanabe K., Nakakura M., Hosokawa T., Hayakawa E., Ito K., Chem. Pharm. Bull., 41, 599-604 (1993).
24. Hwang K. J., "Liposomes, From Biophysics to Therapeutics," ed. by Ostro M. J., Marcel Dekker, Inc., New York and Barsel, 1987, pp. 109-156.
25. Juriano R. L., Stamp D., Biochem. Biophys. Res. Commun., 63, 651-658 (1975).
26. Sato Y., Kiwada H., Kato Y., Chem Pharm. Bull., 34, 4244-4252 (1986).
27. Allen T. M., Hansen C., Rutledge J., Biochim. Biophys. Acta, 981, 27-35 (1989).
28. Mizumoto H., Karasawa A., Jpn. J. Pharmacol., 61, 251-253 (1993).
29. Sato H., Nagashima K., Nomura H., Mochizuki H., Kashiwagi T., Karasawa A., Nishikawa S., J. Toxicol. Pathol., 12, 97-104 (1999).
30. Bangham A. D., Standish M. M., Watkins J. C., J. Mol. Biol., 13, 238-252 (1965).
31. Hope M. J., Bally M. B., Webb G., Cullis P. R., Biochim. Biophys. Acta, 812, 55-65 (1985).
32. Magin R. L., Weinstein J. N., "Liposome Technology," Vol. 3, ed. by Gregoriadis G., CRC Press Inc., Florida, 1984, p. 142.
33. Yamamoto S., "Shishitsu I (Shin Seikagaku Kohza 4)," ed. by Akanuma Y., Tsukiyama Y., Nagai K., Yamamoto A., Tokyo Kagaku Dohjin, Tokyo, 1993, pp. 187-206.
34. Scieszka J. F., Vidmar T. J., Hayners L. C., Cho M. J., Int. J. Pharmaceut., 45, 165-168 (1988).
35. Rotenberg M., Rubin M., Bor A., Meyuhas D., Talmon Y., Lichtenberg D., Biochim. Biophys. Acta, 1086, 265-272 (1991).
36. Li J., Caldwell K. D., J. Pharm. Sci., 83, 1586-1592 (1994).
37. Férézou J., Lai N. T., Leray C., Hajiri T., Frey A., Cabaret Y., Courtieu J., Lutton C., Bach A. C., Biochim. Biophys. Acta, 1213, 149-158 (1994).
38. Handa T., Saito H., Miyajima K., Biochemistry, 29, 2884-2890 (1990).
39. Takino T., Nakajima C., Takakura Y., Sezaki H., Hashida M., J. Drug Targeting, 1, 117-124 (1993).
40. Juliano R. L., Adv. Drug Deliv. Rev., 2, 31-35 (1988).
41. Tall A. R., Tabas I., Williams K. J., Methods Enzymol. 128, 647-657 (1986).
42. Tajima S., Yokoyama S., Yamamoto A., J. Biol. Chem., 258, 10073-10082 (1983).
43. Mims, M. P., Soma M. R., Morriseett J. D., Biochemistry, 29, 6639-6647 (1990).
44. Funahashi T., Yokoyama S., Yamamoto A., J. Biochem. (Tokyo), 105, 582-587 (1989).
45. Saito H., Membrane, 22, 337-342 (1997).
46. Deckelbaum R. J., Hamilton J. A., Moser A., Bengtsson-Olivecrona G., Butbul E., Carpentier Y. A., Gutman A., Olivecrona T., Biochemistry, 29, 1136-1142 (1990).
47. Rojas C., Olivecrona T., Bengtsson-Olivecrona G., Eur. J. Biochem., 197, 315-321 (1991).
48. Hajri T., Férézou J., Lutton C., Biochim. Biophys. Acta, 1047, 121-130 (1990).
49. Liu F., Liu D., Pharm. Res., 12, 1060-1064 (1995).
50. Takino T., Konishi K., Takakura Y., Hashida M., Biol. Pharm. Bull., 17, 121-125 (1994).